Perelman School of Medicine

How cell developmental biology fits into the future of medicine

Ben Stanger, the Hanna Wise Professor in Cancer Research and professor of medicine and cell and developmental biology, discusses his research and publishing his first book, ‘From One Cell: A Journey into Life’s Origins and the Future of Medicine.’

From Penn Medicine News

Uncovering the role of skin microbiome and immune response in cutaneous leishmaniasis

Two new studies led by Phillip Scott of the School of Veterinary Medicine and Elizabeth Grice of the Perelman School of Medicine demonstrate how bacteria found in leishmaniasis skin lesions and an associated immune response drive disease burden and treatment failure—and suggest new possibilities for treatment of the parasitic disease.

Abbey Porter



In the News


Newsweek

Sugar-coated gold nanoparticles could replace some antibiotics

According to a Penn Medicine study, a new therapy involving laser light and sugar-coated gold nanoparticles can reduce tooth decay and infected wounds without needing antibiotics.

FULL STORY →



Associated Press

A new strategy to attack aggressive brain cancer shrank tumors in two early tests

A clinical trial led by Stephen Bagley of the Perelman School of Medicine suggests that targeting two associated proteins with CAR T cell therapy could be a viable strategy for shrinking brain tumors.

FULL STORY →



New Scientist

Alzheimer’s may be caused by a build-up of fat in brain cells

A study by Michael Haney of the Perelman School of Medicine suggests that the root cause of Alzheimer’s is a build-up of fat droplets in brain cells.

FULL STORY →



WHYY (Philadelphia)

Philadelphia hospital program adds psychologists to bridge mental health services for trauma survivors

A new psychology team at the Penn Trauma Violence Recovery Program has provided about 46 survivors with short- and long- term therapy, featuring remarks from Elinore Kaufman and Lily Brown of the Perelman School of Medicine.

FULL STORY →



The Washington Post

Social factors may ‘disproportionately’ affect transplant process

A 2023 study led by researchers at Penn found that 44% of patients evaluated for liver transplants were not placed on organ wait lists, with nearly 17% rejected because of psychosocial or financial reasons. Marina Serper and Tamara Cozzi of Penn Medicine discuss the evaluation process for transplants.

FULL STORY →